09 Apr, EOD - Indian

SENSEX 73847.15 (-0.51)

Nifty 50 22399.15 (-0.61)

Nifty Bank 50240.15 (-0.54)

Nifty IT 32517.35 (-2.19)

Nifty Midcap 100 49582.05 (-0.51)

Nifty Next 50 60664.6 (-0.24)

Nifty Pharma 19976.3 (-1.97)

Nifty Smallcap 100 15256.75 (-0.86)

09 Apr, EOD - Global

NIKKEI 225 31714.03 (-3.93)

HANG SENG 20264.49 (0.68)

S&P 5045.32 (0.83)


Hot Pursuit News

You are Here : Home > News > Hot Pursuit News >

(07 Feb 2025, 08:44)

Stock Alert: ITC, Bharti Airtel, Britannia Industries, Hero Motocorp


Earnings Today:

Mahindra & Mahindra, LIC, Mazagon Dock Shipbuilders, NHPC, Oil India, Wockhardt, 3M India, Archean Chemical Industries, AIA Engineering, Akzo Nobel India, Alembic, Alkem Laboratories, Astra Microwave Products, Balrampur Chini Mills, Balu Forge Industries, Borosil, Caplin Point Laboratories, Century Plyboards, Chemplast Sanmar, Cholamandalam Financial Holdings, Delhivery, Dreamfolks Services will declare their results later today.

Stocks to Watch:

ITC’s consolidated net profit fell 7.5% to Rs 4934.80 crore in Q3 FY25 as compared with Rs 5335.23 crore in Q3 FY24. Net sales increased 8.9% YoY to Rs 18,580.36 crore in Q3 FY25.

Bharti Airtel consolidated net profit soared 460.93% to Rs 16,134.6 crore in Q3 FY25 as against Rs 2,876.4 crore reported in Q3 FY24. Revenue from operations increased 19.07% YoY to Rs 45,129.3 crore in Q3 FY25,

Hero Motocorp reported 1.3% increase in consolidated net profit to Rs 1,107.55 crore in Q3 FY25 as compared with Rs 1093.41 crore in Q3 FY24. Net sales jumped 4.8% YoY to Rs 10,259.89 crore in Q3 FY25.

Britannia Industries’ consolidated net profit increased 4.6% to Rs 581.69 crore on 6.5% jump in net sales to Rs 4,463.30 crore in Q3 FY25 over Q3 FY24.

Zomato’s board approved the change in the name from ‘Zomato Limited’ to ‘Eternal Limited’. The company’s corporate website will transition from zomato.com to eternal.com. It will also change its stock ticker from ZOMATO to ETERNAL.

Dr Reddy’s Laboratories’ subsidiary, Dr. Reddy’s Swiss and Shanghai Henlius Biotech have entered into a license agreement for an in-licensing deal to register and commercialize the subcutaneous and intravenous formulations of the biosimilar product, ‘Daratumumab’ developed by Henlius.

More News
More Company News View Company Information

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +